Back to Journals » Journal of Hepatocellular Carcinoma » Volume 7 » default

Journal of Hepatocellular Carcinoma


Archive: Volume 7, 2020

Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma

Yu Q, Wu L, Ji J, Feng J, Dai W, Li J, Wu J, Guo C

Journal of Hepatocellular Carcinoma 2020, 7:271-288

Published Date: 29 October 2020

miR-3 Encoded by Hepatitis B Virus Downregulates PTEN Protein Expression and Promotes Cell Proliferation

Tang J, Xiao XQ, Jiang Y, Tian Y, Peng Z, Yang M, Xu Z, Gong G

Journal of Hepatocellular Carcinoma 2020, 7:257-269

Published Date: 29 October 2020

Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients

Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, Zhan M, Wang B, Peng F, Gao X, Shi Y, Wen X, Ji Y, Jin Q, Niu J

Journal of Hepatocellular Carcinoma 2020, 7:219-232

Published Date: 23 October 2020

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization

Kobayashi S, Tajiri K, Murayama A, Entani T, Futsukaichi Y, Nagata K, Takahashi K, Yasuda I

Journal of Hepatocellular Carcinoma 2020, 7:181-189

Published Date: 14 October 2020

Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization

Tran Cao H, Tzeng CW, Chun YS, Aloia T, Vauthey JN

Journal of Hepatocellular Carcinoma 2020, 7:155-158

Published Date: 28 September 2020

Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study

Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO

Journal of Hepatocellular Carcinoma 2020, 7:143-153

Published Date: 16 September 2020

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC

Journal of Hepatocellular Carcinoma 2020, 7:117-131

Published Date: 14 September 2020

Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes

Campani C, Bensi C, Milani S, Galli A, Tarocchi M

Journal of Hepatocellular Carcinoma 2020, 7:107-116

Published Date: 30 July 2020

Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging

Moawad AW, Szklaruk J, Lall C, Blair KJ, Kaseb AO, Kamath A, Rohren SA, Elsayes KM

Journal of Hepatocellular Carcinoma 2020, 7:77-89

Published Date: 23 April 2020

Rare Site Hepatocellular Carcinoma Metastasis

Boldo E, Santafe A, Mayol A, Lozoya R, Coret A, Escribano D, Fortea-Sanchis C, Muñoz A, Pastor JC, Perez de Lucia G, Bosch N

Journal of Hepatocellular Carcinoma 2020, 7:39-44

Published Date: 25 March 2020

Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2

Liu T, Li S, Wu L, Yu Q, Li J, Feng J, Zhang J, Chen J, Zhou Y, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C

Journal of Hepatocellular Carcinoma 2020, 7:19-31

Published Date: 18 February 2020

Exploring Metabolic Consequences of CPS1 and CAD Dysregulation in Hepatocellular Carcinoma by Network Reconstruction

Dumenci OE, U AMR, Khan SA, Holmes E, Taylor-Robinson SD

Journal of Hepatocellular Carcinoma 2020, 7:1-9

Published Date: 7 January 2020